Osteo Bi-Flex

Osteo Bi-Flex Triple Strength

Serving
2 Tablet(s)
Per container
20
Form
tablet
UPC
030768031206
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
19
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

8 active ingredients
IngredientAmount% DV
Calories
UNII · 1
10 Calorie(s)
Total Carbohydrates
CarbohydrateUNII · 0
2 Gram(s)1%
Vitamin C
UNII · PQ6CK8PD0R
60 mg67%
Manganese
UNII · 42Z2K6ZL8P
2 mg87%
Sodium
UNII · 9NEZ333N27
35 mg2%
Glucosamine Hydrochloride
UNII · 750W5330FY
1500 mg
Total Carbohydrates
CarbohydrateUNII · 0
100 mg
Chondroitin/MSM Complex
Blend (Combination)
1103 mg
Flagged excipients

1 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

FDA CAERS · adverse event context
19
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Crospovidone · Cellulose · Silica · Magnesium Stearate